We are excited to invite you to St. Louis, which is known for vibrant arts, cultural attractions, and world-class dining, for our 2014 Annual Conference. St. Louis offers many exciting activities, including art museums and galleries, live theater, river cruises, and numerous historical districts with excellent shopping. The central location of the conference hotel, the Hyatt Regency at the St. Louis arch allows easy access to the many restaurants, theaters, arts, and live music. Our conference awards banquet will be held at the St. Louis Zoo, renowned for its innovative approach to animal management, wildlife conservation and research. The Metrolink train offers easy transportation to and from the airport and other destinations.
We are developing a program highlighting advances in clinical oncology. Our keynote speakers have diverse interests and focus on translational medicine with applications of their research into clinical practice. We are fortunate to draw from clinicians and scientists in the Washington University-Barnes Jewish and associated health care system. Dr. Dennis Hallahan is the McDonnell Distinguished Professor and Head of the Department of Radiation Oncology at Washington University will speak on the use of targeted therapies for both radiosensitization of tumor tissues and radioprotection of normal tissues. In addition to his scientific acumen, Dr. Hallahan has an interest in the business and technical aspects of novel drug development. Dr. Kelle Moley is a Professor and Vice Chair of OB/GYN, in addition to being the Director of the Division of Basic Science Research in the Department of OB/GYN at Washington University. Her research encompasses several different aspects of fetal development and maternal nutrition, with regards to various disease states. Her talk is entitled “Generational effect of maternal diet and obesity on the development of cancer in the offspring”. Lastly, Dr. David Curiel is the Director of the Cancer Biology Division and the Director of the Biologic Therapeutics Center at Washington University in St. Louis. His keynote talk will focus on virotherapy of cancer with reference to animals with spontaneous tumors as models for translational clinical research.
A new and exciting addition this year is state of the art (SOTA) speakers, whose talks will consist of new and cutting edge treatments currently in practice. Dr. Chick Weisse will present a current review of the benefits of interventional oncology. We will also hear presentations from Dr. Nicola Mason and Dr. Tony Mutsaers. These SOTA talks are in addition to high quality research abstracts balanced between basic and clinical sciences.
This year marks the 70th anniversary of the movie “Meet me in St. Louis” and we hope that you will do just that!
Kim Selting, DVM, MS, DACVIM, DACVR and Sandra Axiak-Bechtel, DVM, DACVIM
University of Missouri